Skip to main content

Table 1 General characteristics of the patients

From: The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial

 

Group

 
 

n-3 PUFAs (n = 36)

Placebo (n = 35)

P value

Gender (%)

   

 Male

50

60

 

 Female

50

40

.477*

Age (Year, mean ± SD)

54.14 ± 10.53

53.40 ± 15.70

.816**

 Male

58.22 ± 8.02

54.48 ± 16.56

 

 Female

50.06 ± 11.34

51.79 ± 14.78

 

BMIa (kg/m2,mean ± SD)

23.47 ± 3.40

23.22 ± 4.77

.806**

 Male

22.43 ± 2.94

22.26 ± 2.91

 

 Female

24.54 ± 4.68

24.91 ± 6.77

 
  1. *P value is reported based on exact Chi-square test
  2. **P value is reported based on Independent-Samples T Test
  3. aBody mass index
Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us